CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.810
-0.710 (-15.71%)
At close: Jun 17, 2026, 4:00 PM EDT
3.806
-0.004 (-0.11%)
After-hours: Jun 17, 2026, 7:59 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $35.28 million as of June 17, 2026. Its market cap has decreased by -46.60% in one year.
Market Cap
35.28M
Enterprise Value
22.35M
1-Year Change
-46.60%
Ranking
Category
Stock Price
$3.81
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $35.28M, a decrease of -18.46%. That is a compound annual growth rate of -6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 35.28M | -51.74% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 25.05M |
| Longeveron | 24.61M |
| Quantum BioPharma | 24.56M |
| NeuroSense Therapeutics | 24.29M |
| BriaCell Therapeutics | 24.27M |
| Neuphoria Therapeutics | 23.19M |
| Allarity Therapeutics | 22.88M |
| Vistagen Therapeutics | 22.70M |